NEFROLIFE
NEFROLIFE Tablet is a Patented combination medicine that helps to delay the progression of Chronic kidney disease associated with diabetes and hypertension.
Disease Details
Kidney disease can be broadly classified into two types : Chronic kidney disease (CKD) and Acute Kidney injury (AKI). Both if untreated can lead to permanent kidney damage. Long term diabetes and hypertension can lead to CKD.
Each film coated tablet contains:
Accetylcysteine USP – 150mg
Taurine USP – 500mg
The recommended dose of NEFROLIFE is 1 Tablet twice daily after food or as directed by the Physician.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
